Xuejian Yang
300 Guangzhou Road
Nanjing, 210029, China
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The Prognostic Role of HER2 Expression in Patients With Non-Muscle-Invasive Bladder Cancer.
Journal: Clinical genitourinary cancer
Published: March 01, 2026
Overexpression of CDC20 Confer a Poorer Prognosis in Bladder Cancer Identified by Gene Co-Expression Network Analysis.
Journal: Diagnostics (Basel, Switzerland)
Published: September 11, 2025
Bladder-sparing therapy for high-tumor-burden non-muscle invasive bladder cancer: outcomes from high-tumor-burden NMIBC program.
Journal: International urology and nephrology
Published: July 09, 2025
Potential of Urinary Mutation and Methylation Biomarkers in Selecting Candidates for Repeat Transurethral Resection of Bladder Tumor in Non-muscle-invasive Bladder Cancer: A Prospective Multicenter Study.
Journal: European urology open science
Published: May 24, 2025
The potential of organoids in renal cell carcinoma research.
Journal: BMC urology
Published: February 02, 2024
Exosomal MicroRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer.
Journal: Molecular therapy. Nucleic acids
Published: April 22, 2019
Serum metabolomic analysis of human upper urinary tract urothelial carcinoma.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: November 29, 2014
TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population.
Journal: International journal of genomics
Published: September 27, 2013
Effects of TSP-1-696 C/T polymorphism on bladder cancer susceptibility and clinicopathologic features.
Journal: Cancer genetics
Published: September 25, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026